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he RNA-editing enzyme adenosine deaminase that
acts on RNA (ADAR1) deaminates adenosines to
inosines in double-stranded RNA substrates. Currently,
it is not clear how the enzyme targets and discriminates
different substrates in vivo
 
.
 
 However, it has been shown
that the deaminase domain plays an important role in distin-
guishing various adenosines within a given substrate RNA
in vitro
 
.
 
 Previously, we could show that 
 
Xenopus
 
 ADAR1 is
associated with nascent transcripts on transcriptionally active
lampbrush chromosomes, indicating that initial substrate
binding and possibly editing itself occurs cotranscriptionally.
Here, we demonstrate that chromosomal association depends
T
 
solely on the three double-stranded RNA-binding domains
(dsRBDs) found in the central part of ADAR1, but not on
the Z-DNA–binding domain in the NH
 
2
 
 terminus nor the
catalytic deaminase domain in the COOH terminus of the
protein. Most importantly, we show that individual dsRBDs
are capable of recognizing different chromosomal sites in
an apparently speciﬁc manner. Thus, our results not only
prove the requirement of dsRBDs for chromosomal targeting,
but also show that individual dsRBDs have distinct in vivo
localization capabilities that may be important for initial
substrate recognition and subsequent editing speciﬁcity.
 
Introduction
 
Adenosine deaminases that act on RNA (ADARs)* are a
family of RNA-editing enzymes that catalyze the hydrolytic
deamination of adenosines to inosines in a diverse group of
mostly double-stranded RNA substrates. As inosine base-
pairs like guanosine, the editing event frequently leads to a
codon exchange when the substrate is an mRNA (Bass,
1997). Having first been described in 
 
Xenopus
 
 oocytes and
embryos, ADAR-like activity has subsequently been found
in every metazoan tissue tested, and to date, three distinct
ADAR enzymes are cloned and characterized from various
organisms, termed ADAR1, ADAR2, and ADAR3 (Keegan
et al., 2001). In addition to RNA editing, ADAR1 was recently
suggested to be involved in the regulation of nuclear translation
(Herbert et al., 2002). Structurally, all ADARs possess a con-
served deaminase domain in their COOH terminus required
for enzymatic activity as well as one or several copies of the
double-stranded RNA-binding domain (dsRBD) in their
central region. In addition, ADAR1 proteins have a long
 
NH
 
2
 
 terminus that contains two tandemly arranged Z-DNA–
binding domains (ZBDs), termed Z-
 
 
 
 and Z-
 
 
 
 (Keegan et
al., 2001; see Fig. 1).
Substrates of ADARs include viral RNAs and endogenous
transcripts. Viral RNAs are frequently edited promiscuously,
but can also be edited specifically affecting only a few resi-
dues. However, endogenous substrates are mostly edited
specifically (Bass, 1997). During nonspecific editing, up to
50% of adenosines can be converted into inosines with the
extent of editing being affected both by neighboring bases
and the length of contiguous duplex regions present (Lehmann
and Bass, 1999). Such editing is thought to be part of a cellular
antiviral defense program; a view that is supported by the
observed transcriptional interferon induction of mammalian
ADAR1 (Patterson et al., 1995).
In contrast, site-specific editing is less well understood and
has only been described for a few RNAs including those
encoding several subunits of the mammalian glutamate-gated
ion channel family and the serotonin 2C receptor (Burns et
al., 1997; Higuchi et al., 2000). Interestingly, both ADAR1
and ADAR2 edit these transcripts, but preferentially deaminate
different adenosines within them. Consequently, a key question
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regarding the function of these enzymes is not only how
they specifically recognize substrate RNAs in vivo but also
how they target a particular adenosine within a given tran-
script (Hurst et al., 1995; Lehmann and Bass, 2000).
To date, all described substrates have, or are predicted to
have, an extensive duplex structure that defines the site of ed-
iting. This, in turn, suggests a central role of the dsRBDs for
substrate binding that has been confirmed by the observed
reduction or loss of enzymatic activity when individual
dsRBDs are deleted or mutated. Mutational analysis also
shows that dsRBDs are functionally nonequivalent with some
domains being dispensable for enzyme function, whereas oth-
ers are essential (Lai et al., 1995; Liu and Samuel, 1996).
Therefore, this raises the possibility that both the number
and type of dsRBDs found in different ADAR proteins does
contribute to overall substrate specificity. In support of this,
chimeric proteins, where the first two dsRBDs from ADAR1,
are replaced by the two dsRBDs from the RNA-dependent
protein kinase PKR loose editing selectivity on endogenous
substrates (Liu et al., 2000). Moreover, recent in vitro work
on ADAR2 suggests that the dsRBDs help to define the edit-
ing site by increasing conformational flexibility of residues
adjacent to the edited site. This is thought to allow base flip-
ping of the adenosine, which has been shown to occur during
the deamination reaction (Yi-Brunozzi et al., 2001).
However, structural analyses reveal that dsRBDs interact
with the RNA sugar–phosphate backbone without making
base-specific contacts (Ryter and Schultz, 1998; Ramos et
al., 2000). Therefore, dsRBDs are assumed to recognize spe-
cific structures rather than a consensus sequence. Nonethe-
less, because the structure of an RNA is also governed by the
underlying sequence, binding of dsRBDs to specific struc-
tures might also select for certain sequences. Furthermore, a
lack of sequence specificity does not preclude individual
dsRBDs from having distinct in vivo functions. For in-
stance, the five dsRBDs of the 
 
Drosophila
 
 Staufen protein
have been shown to exhibit individual functions with regard
to translational control and localization of substrate RNAs
(Micklem et al., 2000). Moreover, it was recently shown
that human ADAR1 has an NLS that overlaps almost en-
tirely with the third dsRBD (Eckmann et al., 2001). Also,
nuclear export or regulation of nuclear import has been at-
tributed to dsRBDs (Brownawell and Macara, 2002). Simi-
larly, some dsRBDs can act as homodimerization domains
(unpublished data). Therefore, it is becoming increasingly
apparent that proteins containing multiple dsRBDs may use
each domain individually in vivo, thus, maximizing func-
tional diversity, possibly by interacting with other protein
components (for review see Doyle and Jantsch, 2002).
In addition to dsRBDs, the deaminase domain has been
shown to be important for substrate recognition by ADARs.
This domain can also be found conserved in a related family
of tRNA-editing enzymes known as adenosine deaminases
that act on tRNA (ADATs). ADATs specifically edit ade-
nosines in the anticodon regions of several tRNAs (for re-
view see Gerber and Keller, 2001). Unlike ADARs, they lack
dsRBDs, ZBDs, or any other described nucleic acid binding
motifs, but seemingly act as heteromers. Therefore, it is be-
lieved that deaminase domains themselves can confer sub-
strate specificity, thus raising the possibility that the same
may be the case for ADARs. Furthermore, it was recently
shown that deaminase domains of ADAR1 and ADAR2
have a dominant role in defining substrate specificity com-
pared with the dsRBDs. When the deaminase domains were
exchanged between ADAR1 and ADAR2, the resulting chi-
meric proteins had a preference to edit reporter constructs
according to the origin of the deaminase domain that they
contained. However, editing was not restored to endogenous
levels, underscoring the importance of additional elements
such as dsRBDs for proper enzyme function. Moreover, ed-
iting was only monitored for a particular substrate site, but
not on a genome-wide level (Wong et al., 2001).
In light of this, and the previously described findings, we
reasoned that although ADAR’s dsRBDs may not be re-
quired for final identification of target adenosines, they may
bind specifically to favorable substrate structures in vivo
 
,
 
 thus
giving an initial level of discrimination at the chromosomal
level. Such discrimination may further be enhanced through
the differences exhibited between individual dsRBDs. There-
fore, we set out to determine which elements within 
 
Xenopus
 
ADAR1 are required for chromosomal localization and
which role individual dsRBDs might play in transcript associ-
ation. We had shown previously that ADAR1 can be found
associated with the nascent RNP matrix on 
 
Xenopus
 
 lamp-
brush chromosomes, but also with a particular chromosomal
structure termed the “special loop” (Eckmann and Jantsch,
1999). The special loop is transcriptionally silent and seem-
ingly represents a storage site for ADAR1 and other RNA-
binding proteins possibly to regulate intranuclear enzyme
concentration (unpublished data). In contrast, localization of
ADAR1 on all other chromosomal sites, reflects the enzyme’s
ability to associate with the nascent RNP matrix found on
transcriptionally active chromosome loops.
Lampbrush chromosomes are giant meiotic chromosomes
where individual transcription units can be visualized under
the normal light microscope. The nascent RNP matrix and
attached proteins can also be discriminated on transcription-
ally active genes. Thus, differences in RNP composition of
individual genes can be monitored microscopically.
 
Results
 
The catalytic deaminase domain is dispensable for 
chromosomal localization
 
ADATs lack any dsRBDs, yet the different members of this
protein family can edit individual adenosines in tRNAs spe-
cifically (Gerber and Keller, 2001). Furthermore, it was re-
cently shown that the deaminase domains of ADAR1 and
ADAR2 play an essential role in determining substrate spec-
ificity (Wong et al., 2001). To assess the role of the deami-
nase domain in chromosomal localization, we removed the
3
 
 
 
 end of the ADAR1.1 cDNA immediately downstream of
the third dsRBD, thus deleting this domain (Fig. 1). This 
 
 
 
-
deaminase construct was myc-tagged at both ends, in vitro
transcribed and the resulting RNA microinjected into 
 
Xeno-
pus
 
 oocytes. After allowing in vivo translation to occur,
lampbrush chromosome preparations were made and the in-
tranuclear expression of the construct was followed by im-
munofluorescence using the monoclonal anti–myc 9E10 an-
tibody (mAb 9E10). To allow a comparison with full-lengthT
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ADAR1, all slides were costained for the endogenous pro-
tein using the SAT3 antiserum described previously (Eck-
mann and Jantsch, 1999). In addition, full-length myc-
tagged ADAR1.1 was injected as a positive control. This
construct was described previously and had been shown to
mimic endogenous staining (Eckmann and Jantsch, 1999).
Removal of the deaminase domain had no effect on chro-
mosomal localization with all chromosomes being efficiently
labeled. When compared with the endogenous protein, the
 
 
 
-deaminase construct was distributed on individual chromo-
somes similar to endogenous ADAR1 with all loops labeled by
the endogenous protein also being labeled by the injected con-
struct. Such colocalization was also observed for the full-
length construct (Fig. 2 A). Expression of injected constructs
was verified by Western blotting of nuclei and cytoplasmic ex-
tracts using mAb 9E10 (Fig. 2 B). However, it should be
noted that the SAT3 antiserum was generated against the
NH
 
2 
 
terminus of 
 
Xenopus
 
 ADAR1. Therefore, the SAT3 anti-
serum can also detect the injected 
 
 
 
-deaminase and full-
length constructs. Nonetheless, SAT3 staining looked virtu-
ally identical in both injected and uninjected control oocytes
(Eckmann and Jantsch, 1999; unpublished data).
 
The double-stranded RNA-binding domains are 
essential and sufficient for chromosomal targeting
 
Having found that the deaminase domain was dispensable
for chromosomal localization, we next wanted to define
what other regions could be responsible for targeting the
protein to chromosomes and transcriptionally active chro-
mosomal loops. Previously, we deleted the majority of the
 
NH
 
2
 
 terminus up to and including most of the ZBD and
found that this had no effect on chromosomal localization
(Eckmann and Jantsch, 1999). Therefore, it was apparent
that the central region of the protein containing the NLS
and three dsRBDs was most likely responsible for chromo-
somal and transcript association.
Figure 1.  Schematic representation of Xenopus ADAR1 and mutant 
constructs used in this paper. The 1,271–amino acid Xenopus 
ADAR1 protein is depicted to scale at the top with mutant constructs 
shown underneath. Subregions of the protein are indicated as 
follows: REP, 11-aa peptide repeats; ZBD, Z-DNA binding domain; 
NLS, nuclear localization signal; dsRBDs, double-stranded RNA-
binding domains; and Deaminase, catalytic deaminase domain. The 
ability of constructs to label chromosomes (Chr) and enrich at the 
special loop (Sp. loop) is shown on the right and indicated either as 
positive ( ), negative ( ), or patchy ( / ). Deletion of the deaminase 
domain (  deaminase) had no effect on chromosomal labeling and 
special loop enrichment. Expression of the central part of the protein 
from the end of the ZBD up to the end of dsRBD3 (dsRBD1-2-3) 
resulted in the same localization pattern as the wild-type protein, 
which is indicated by chromosomal association and special loop 
enrichment. Conversely, removal of the three dsRBDS from the 
full-length protein (  dsRBDs) resulted in a loss of all nuclear staining. 
Replacement of the endogenous dsRBDs with single dsRBDs 
(dsRBD2), duplicated dsRBDs (dsRBD2-2) or triplicated dsRBDs 
(dsRBD2-2-2) failed to restore normal chromosomal association. 
All constructs gave patchy labeling ( / ) and none enriched at 
the special loop (for simplicity, only dsRBD2 containing constructs 
are shown).
Figure 2. Deletion of the deaminase domain does not affect 
chromosomal localization. (A) RNA transcribed from full-length 
myc-tagged ADAR1 and a myc-tagged construct where the deaminase 
domain had been removed was injected individually into Xenopus 
oocytes. Lampbrush chromosome preparations were made and in 
vivo translation of each RNA was followed using the anti–myc mAb 
9E10 and a secondary FITC-labeled antibody (FITC). Simultaneously, 
all preparations were stained for endogenous ADAR1 using the 
SAT3 antisera that was detected with a secondary TRITC-labeled 
antibody (TRITC). Injection of full-length ADAR1 (top) resulted in 
normal chromosomal localization compared with the endogenous 
protein. This was also the case when the deaminase domain 
was removed (bottom,   Deaminase), indicating at least at the 
chromosomal level that this domain does not play a role in targeting 
ADAR1 to nascent transcripts. Preparations were also stained with 
DAPI, and images of chromosomes were taken by differential 
interference contrast (NOM). Bar, 20  m. (B) Western blot analysis 
of oocyte germinal vesicles (GV) and cytoplasms (CYT) from uninjected 
oocytes and oocytes expressing myc-tagged ADAR1 constructs 
to verify expression. Both myc-tagged versions express well and 
accumulate in the nucleus and are easily detected with the mAb 
9E10. Cytoplasmic signals are seen 24 h after injection, but diminish 
over time as the protein is transported into the nucleus. In comparison, 
no signal is detected in uninjected oocytes indicating the specificity 
of mAb 9E10 for the injected constructs. Translated products 
correspond nicely to the predicted molecular masses of 175 kD 
(full-length ADAR1) and 130 kD (  Deaminase) indicated by arrows. 
Breakdown products can be observed at 120 kD (full-length) and 
100 kD (  Deaminase). However, molecular mass calculations 
indicate that proteolytic cleavage has to occur upstream of the 
dsRBDs and, therefore, does not affect the RNA-binding capacity of 
the resulting fragments.T
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To test this we took two approaches. First, we deleted the
three dsRBDs from the full-length myc-tagged ADAR1, fus-
ing the ZBD, NLS, and the deaminase domain in frame. As
expected, this construct failed to stain any intranuclear
structures (Fig. 3), whereas Western blots of nuclei and cy-
toplasms clearly showed that the construct had properly ex-
pressed and accumulated in the nucleus (unpublished data).
Second, the converse experiment was performed by injecting
a construct that contained only the NLS and the three
dsRBDs. A fragment that spanned from the end of the
ZBD, up to and including all of the third dsRBD, was myc-
tagged at either end. Injection of this construct resulted in
chromosomal labeling, and colocalization with the endoge-
nous protein including enrichment at the special loop on
chromosome 3 (Eckmann and Jantsch, 1999). Although this
construct contained all three dsRBDs and the NLS, we were
also aware that it contained the COOH terminus of the
ZBD. To ensure that these extra amino acids had no effect
on chromosomal targeting, the remainder of the Z-
 
 
 
 do-
main was removed. Again, normal chromosomal labeling
and colocalization with endogenous ADAR1 including en-
richment at the special loop was observed (Fig. 3).
 
Individual dsRBDs can target ADAR1 
to transcription units
 
Knowing that both the deaminase domain and the ZBDs
were not required for chromosomal localization and that a
minimum construct containing the NLS and dsRBDs
would label chromosomes normally, we turned our atten-
tion to defining the role of the dsRBDs in more detail.
We were especially keen to determine the role individual
dsRBDs play in chromosomal localization given the fact that
it had been demonstrated that dsRBDs, from this and other
proteins, can differ functionally in vivo (Micklem et al.,
2000; Eckmann et al., 2001; Strehblow et al., 2002). There-
fore, we tested constructs that either contained single
dsRBDs or tandemly arranged duplications or triplications
of a specific domain. Proteins containing either duplications
or triplications of individual dsRBDs were assumed to bind
RNA with a greater affinity and might, therefore, accentuate
potential differences exhibited by individual dsRBDs. Con-
structs were generated using a PCR strategy that maintained
the precise spacing between each dsRBD present in the wild-
type protein. Maintaining the proper spacing between indi-
Figure 3. The dsRBDs are necessary and sufficient for chromosomal 
association. Lampbrush chromosome preparations were made from 
oocytes injected with RNA transcribed from either of two myc-
tagged constructs. In vivo translation of both constructs was followed 
using mAb 9E10 and a secondary FITC-labeled antibody (FITC). 
Expression of the central part of the protein from the end of the Z-  
domain up to the end of dsRBD3 (top, dsRBD1-2-3) results in normal 
chromosomal association and special loop enrichment. In contrast, 
removal of the three dsRBDs from the full-length protein (bottom,
  dsRBDs) causes loss of chromosomal and intranuclear staining. 
All preparations were costained for endogenous ADAR1 using 
the SAT3 antiserum and detected with a secondary TRITC-labeled 
antibody (TRITC). Enrichment at the special loop on the third 
chromosome is marked by arrows. Preparations were also stained 
with DAPI, and images of chromosomes were taken by differential 
interference contrast (NOM). Bar, 20  m.
Figure 4. Northwestern analysis of dsRBDs constructs. The RNA-
binding assay of bacterially expressed dsRBD-GST fusion proteins 
was performed with rI/rC (A). In parallel, the same extracts were 
run on a gel and stained with Coomassie brilliant blue to allow 
quantification of the recombinant protein (B). The ratio of signal 
to protein was quantified by laser densitometry and is depicted 
graphically (C). The number and type of dsRBDs are indicated. 
Also shown is the empty pGEX vector used as a negative control, 
whereas the second dsRBD of XlrbpA is included as a positive 
control. Of the single domains, dsRBD2 and dsRBD3 were found 
to be the best RNA binders. Constructs containing duplications 
of individual dsRBDs showed a higher affinity for rI/rC, whereas 
triplicating individual dsRBDs further enhanced this affinity.T
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vidual domains seemed important, as it had been shown that
splice variants of human ADAR1 with altered spacings be-
tween dsRBDs have different editing capabilities (Liu et al.,
1997, 1999; Liu and Samuel, 1999). To simplify all clon-
ings, unique restriction sites were introduced in the full-
length myc-tagged construct flanking the dsRBDs, thus
allowing their easy removal and replacement by individual
domains. Furthermore, GFP was introduced as a second
tagging system to allow the simultaneous injection and sub-
sequent detection of two different constructs within the
same oocyte.
To evaluate the RNA-binding ability of these constructs
in vitro and to compare them with each other, all dsRBD
combinations (single, duplications, and triplications) were
expressed as GST fusion proteins and tested in Northwest-
ern assays using rI/rC as a probe. At the same time, the sec-
ond dsRBD of 
 
Xenopus laevis
 
 RNA-binding protein A (Xl-
rbpA) was used as a positive control for RNA-binding as this
domain binds RNA with very high affinity (Krovat and
Jantsch, 1996) and had been used previously as an internal
standard to quantify the RNA-binding capacity of the indi-
vidual dsRBDs of 
 
Xenopus
 
 ADAR1 (Brooks et al., 1998). To
determine the amount of recombinant protein in the ex-
tracts, a second gel was run in parallel and stained with Coo-
massie brilliant blue. The autoradiogram and Coomassie-
stained gels were quantified using laser densitometry, and
the amount of RNA bound was normalized to the amount
of recombinant protein present in the extracts (Fig. 4).
Among the single domains, dsRBD2 and dsRBD3 were
found to be the best RNA binders reflecting our previously
published data (Brooks et al., 1998). Duplications of indi-
vidual dsRBDs did bind rI/rC better than a single dsRBD,
whereas triplicated domains had an even higher affinity for
double-stranded RNA (Fig. 4).
To assess the role of individual domains in chromosomal
targeting, we initially compared the distribution of single
domain constructs with that of the endogenous protein. In
these experiments, no single domain was able to mimic en-
dogenous staining including enrichment at the special loop.
Interestingly, however, any individual domain was capable
of restoring at least some level of chromosomal localization.
Unlike the distribution of full-length ADAR1, constructs
bearing dsRBD1 or dsRBD2 predominantly highlighted
a few loops on all chromosomes (Fig. 5), whereas the
dsRBD3-containing construct showed a rather weak and
relatively homogeneous staining (unpublished data). More-
over, chromosomal loops that were labeled by individual
domains were always stained by the endogenous antibody,
but not vice versa (Fig. 5). To ensure that the observed la-
beling was not due to insufficient incubation time, and
thus, reduced translation product levels, oocytes were cul-
tured for up to 10 d. Assessment at different time points
showed that labeling increased slightly over the first 48-h
period, but remained constant for the remainder of the ex-
periment. Additionally, Western blots of injected oocytes
were made to control for equal and sufficient protein pro-
duction (unpublished data).
Interestingly, chromosomal loops labeled by the injected
constructs frequently appeared at the same position along the
arms of each meiotically paired homologue (Fig. 5, arrows).
 
Therefore, it is obvious that these constructs specifically target
the same loops on each homologue
 
.
 
 On the one hand, this
suggests that individual dsRBDs might be capable of specifi-
cally binding to certain RNAs. On the other hand, labeling of
a few selected loops could also be the result of different RNA
concentrations and turnover rates at these chromosomal sites.
Therefore, a construct containing only a single dsRBD and
thus being a weak RNA binder might only accumulate at sites
of high RNA concentrations, giving the impression of specific
chromosomal targeting. To discriminate between these possi-
bilities, we took two approaches. First, we reasoned that if the
observed labeling of homologous sites was simply due to weak
RNA binding, increasing the numbers of individual dsRBDs
in a construct, and hence the total RNA-binding capability,
should restore normal chromosomal labeling. Conversely, if
chromosomal targeting was truly specific, labeling of homolo-
gous sites by such a construct would continue. Second, if in-
dividual dsRBDs are capable of targeting different chromo-
somal loci, it should be possible to visualize this directly in
vivo by comparing the localization of different dsRBD con-
structs on the same chromosome.
 
Increasing RNA binding does not restore normal 
chromosomal labeling
 
To assess the role RNA-binding plays in chromosomal tar-
geting, we wanted to compare the localization of constructs
with different RNA-binding abilities. To maintain a poten-
tial binding specificity, we simultaneously injected con-
structs containing either duplications or triplications of the
same dsRBD. Northwestern assays had shown that con-
structs carrying duplications or triplications of the same
dsRBD showed a gradually increasing RNA-binding ability
(Fig. 4). To allow a simultaneous detection of the resulting
proteins, constructs carrying a duplication of a particular
dsRBD were tagged with GFP, whereas constructs carrying
a triplication of the same dsRBD were attached to the myc
tag. Interestingly, efficient translation was only observed
when the RNAs encoding these constructs were injected
consecutively. In contrast, simultaneous injection of both
constructs resulted in reduced translation and, thus, ineffi-
cient detection of either construct on chromosomes. How-
ever, it should be noted that the outcome of the experi-
ments was not influenced by the order in which the two
constructs were injected (unpublished data). Surprisingly,
neither duplication nor triplication of any dsRBD did re-
store normal chromosomal labeling. Even though addi-
tional dsRBDs did lead to a slight increase in overall chro-
mosomal localization, targeting appeared specific with
chromosomes being labeled at identical positions along the
length of each homologue by both duplication and triplica-
tion constructs (Fig. 5).
 
Individual dsRBDs can target different transcripts 
on homologous chromosomes
 
Thus far, our experiments could demonstrate that individual
dsRBDs are capable of targeting specific chromosomal loci.
Moreover, increasing the level of RNA binding slightly in-
creased chromosomal association of the protein, but it re-
mained restricted to a few sites and failed to restore homoge-T
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neous chromosomal localization comparable to that of wild-
type ADAR1. Next, we wanted to determine whether indi-
vidual dsRBDs can target to different transcripts in vivo. To
accomplish this, constructs containing different dsRBDs
were tagged with either GFP or myc, injected, and subse-
quently detected within the same oocyte. To verify that the
different tags did not alter the localization of the resulting
fusion proteins, we initially coinjected identical myc- and
GFP-tagged constructs and compared their localization to
each other. Additionally, synthesis and nuclear accumula-
tion of the resulting constructs was monitored by Western
blotting of hand-enucleated oocytes and isolated germinal
vesicles. As expected, the different tagging systems showed
no adverse effect on the chromosomal distribution of the re-
sulting fusion proteins, leading to a complete overlap in the
localization of both myc- and GFP-tagged protein (Fig. 6).
Initially, we compared the distribution of single dsRBD
constructs to one another, whereas in subsequent experi-
ments, the intranuclear distribution of constructs containing
duplications or triplications of individual domains was com-
pared. Differences in chromosomal distribution could al-
ready be observed with single domain constructs (Fig. 5). A
construct containing a single dsRBD1 showed weak labeling
on many loops along the entire length of a chromosome, but
Figure 5. Individual dsRBDs can lead to ADAR1 
enrichment on different transcription units. RNA 
transcribed from full-length myc-tagged ADAR1 
constructs with either a single copy of dsRBD1 (A) 
or dsRBD2 (B) in place of the three endogenous 
dsRBDs was injected into oocytes. Translation of 
both constructs was followed using mAb 9E10 and 
a secondary FITC-labeled antibody. Simultaneously, 
all preparations were stained for endogenous 
ADAR1 using the SAT3 antisera (endogenous). 
Preparations were also stained with DAPI, and 
images of chromosomes were taken by differential 
interference contrast (NOM). Both dsRBD 
constructs were able to restore at least some level 
of chromosomal labeling, but at reduced levels 
compared with the endogenous ADAR1 staining. 
Interestingly, labeling often appeared at the same 
position along the arms of each homologue 
(A and B, arrows) indicating specific targeting to 
the same chromosomal loops. (C) To determine the 
influence of overall RNA–binding strength, constructs 
containing a duplication (dsRBD 2-2 GFP) or a 
triplication (dsRBD 2-2-2 MYC) of dsRBD were 
tagged with GFP and myc, respectively, injected, 
and detected within the same oocyte. Both constructs 
did label the same chromosomal sites (C, arrows), 
thus leading to a homogeneous yellow labeling in 
the overlay (merge). (D) To directly compare two 
individual dsRBDs on the same chromosome, 
RNA, transcribed from GFP-tagged ADAR1 
containing a single dsRBD1, was coinjected with 
RNA made from a myc-tagged ADAR1 construct 
containing a single dsRBD2. Translation of the GFP-
tagged construct was followed using appropriate 
antibodies. The dsRBD2-containing construct 
shows specific enrichment at a few chromosomal 
sites (D, top arrows), whereas the dsRBD1-containing 
construct shows a more homogeneous chromosomal 
staining. However, a few sites are specifically 
highlighted by the dsRBD1-containing constructs 
and, thus, appear green in the merged image 
(D, bottom arrows). Merged images of dsRBD1 
and dsRBD2 labeling are shown (merge) as well as 
images of the chromosomes taken by differential 
interference contrast (NOM). Bar, 20  mT
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also highlighted a few loops specifically. In contrast, a con-
struct containing a single dsRBD2 showed rather specific la-
beling of a few sites. Most importantly, the overlay image
clearly indicated that a few sites were exclusively labeled by
either one of the two constructs.
Nonetheless, the observed differences were more easily de-
tected when the number of dsRBDs present in a construct
was increased (Fig. 6). The most prominent differences were
observed when comparing constructs carrying triplications
of dsRBD1 with those containing triplications of dsRBD2.
Moreover, as with the individual injections multiplications
of dsRBDs1 or 2 led to a patchy chromosomal distribution.
A direct comparison of these two constructs showed that
some chromosomal loops were labeled exclusively by either
of the two proteins (Fig. 6). Constructs containing multiple
copies of dsRBD3, however, stained chromosomes only
moderately, but relatively homogeneously (Fig. 6). This
finding suggests that some dsRBDs can specifically target a
subset of transcriptionally active chromosomal sites to asso-
ciate with the nascent RNP matrix.
 
Discussion
 
dsRBDs are necessary and sufficient 
for chromosomal targeting
 
We set out to determine which elements within 
 
Xenopu
 
s
ADAR1 are responsible for chromosomal targeting and
could show that the dsRBDs alone are necessary and suffi-
cient to accomplish this. Moreover, individual dsRBDs ap-
pear to have the capability to selectively recognize and target
ADAR1 to a subset of chromosomal sites and, thus, to spe-
cific RNAs being transcribed there.
Interestingly, our data demonstrated that the two ZBDs
located in the NH
 
2 
 
terminus of ADAR1 are neither neces-
sary nor sufficient for chromosomal targeting. This is some-
what surprising, as it had been suggested that these domains
Figure 6. Individual dsRBDs can target 
ADAR1 to different subsets of loops. Double 
injections of RNA from different myc- and GFP 
triplication constructs are shown as indicated. 
Translation of the myc constructs was detected 
using mAb 9E10 and a secondary TRITC-labeled 
antibody (TRITC), whereas the GFP constructs 
were detected using an anti–rabbit GFP antibody 
and a secondary FITC-labeled antibody (FITC). 
Merged enlargements are shown between 
(merge). (A) Injection of identical constructs 
label the same chromosomal sites. Shown is a 
double injection of RNA made from dsRBD1 
triplications that were either myc- or GFP-tagged. 
Both tagged versions label the chromosomes 
equally well and target to the same sites and 
loops (e.g., arrows). Such a complete overlap 
becomes even more apparent when similar 
regions of the chromosome from each channel 
(boxed) are enlarged, colored, and merged. 
(B and C) Different dsRBDs target ADAR1 to 
different chromosomal sites. RNA made from 
GFP-tagged dsRBD1 triplication was injected 
into oocytes followed by injection of RNA 
either from myc-tagged dsRBD2 triplication (B) 
or myc-tagged dsRBD3 triplication (C). Two 
different representative chromosomal sites are 
shown in B. Each construct labels chromosomes 
differently with some sites being labeled by one 
construct not being labeled by the other (arrows). 
Consequently, in the merged images, there is 
no complete overlap of staining. Together, this 
demonstrates the capability of individual dsRBDs 
specifically targeting different transcription units. 
Images of chromosomes taken by differential 
interference contrast (NOM) are also shown. 
Bar, 10  m. (D) Western blot analysis of oocyte 
germinal vesicles (GV) and cytoplasms (CYT) 
from uninjected oocytes and oocytes expressing 
myc- and GFP-tagged ADAR1 constructs 
shown in A–C to verify expression. Translated 
products correspond nicely to the predicted 
molecular masses of  180 kD (arrows).T
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might be involved in targeting the protein to sites of tran-
scription where DNA might be in a Z-DNA conformation
due to partial unwinding occurring during transcription
(Herbert, 1996). Considering that the lateral loops on lamp-
brush chromosomes represent sites of active transcription,
one might expect the ZBDs to enhance the accumulation of
the protein at transcriptionally active loops or the underly-
ing chromatin. However, to our estimation, removal of the
ZBDs had no adverse effect on the efficiency with which the
protein did localize to lampbrush chromosomes. Nonethe-
less, in vivo–editing assays performed on artificial substrates
demonstrated recently that the ZBDs are dispensable for the
editing of substrates longer than 15 bp, but are seemingly
important for very short substrates (Herbert and Rich,
2001). Thus, ZBDs might be dispensable for targeting and
subsequent editing of an average RNA–polymerase II tran-
script, but might be primarily important for the editing of
endogenous, short-structured or -viral RNAs.
We could also demonstrate that the deaminase domain is
dispensable for targeting ADAR1 to nascent transcripts.
This is an interesting finding, especially when considering
that this domain plays a dominant role in defining individ-
ual adenosines to be edited (Wong et al., 2001). Moreover,
the tRNA-editing enzymes ADATs lack any dsRBDs, but
can still edit their substrates specifically. Thus, it is generally
assumed that deaminase domains are able to discriminate
substrates by themselves. However, our results indicate that
the deaminase domain in ADAR1 only allows discrimina-
tion of individual adenosines after the protein has associated
with the nascent RNP matrix. The initial RNA-binding and
recognition event seemingly occurs independently of the
deaminase domain.
 
Chromosomal targeting versus editing
 
Throughout the course of this work, we have concentrated
on determining the role different domains of ADAR1 play
in mediating chromosomal localization and transcript asso-
ciation in vivo. In contrast, other works primarily investi-
gated the contribution of dsRBDs on editing efficiency of a
particular set of substrate sites. Maybe not surprisingly, in
these works, mutation of the editing enzyme invariantly led
to a decrease in editing efficiency on these substrates (Lai et
al., 1995; Liu and Samuel, 1996; Liu et al., 2000).
However, here we focused on the contribution dsRBDs
might play on RNA association at the genome-wide level.
Therefore, our finding that different nascent transcripts can
be targeted dependent on the type of dsRBD present sug-
gests that whereas editing efficiency of a particular substrate
site might decrease, other (potentially novel) sites within the
genome might be targeted with increased efficiency by our
mutant constructs. In this context, it is also worth mention-
ing that only a small number of ADAR1 substrates are
known today. However, it is estimated that in rat brain, for
instance, up to 10% of all mRNAs might be edited, thus
leaving a large number of ADAR1 substrates to be discov-
ered (Paul and Bass, 1998).
Nonetheless, given the large number of chromosomal sites
being targeted by both wild-type and mutant-ADAR1 con-
structs it seems rather unlikely that all encode true editing
substrates. Instead, it seems possible that ADAR1 associates
with hnRNAs independent of whether they contain editing
sites or not. Furthermore, association with hnRNAs might
occur via interaction with other RNPs rather than by active
RNA binding, a view that is supported by the observed asso-
ciation of ADAR1 with large RNP particles (Raitskin et al.,
2001). Thus, the differences in distribution of our mutant
constructs do not necessarily reflect binding to novel sub-
strates. Nonetheless, our results clearly indicate that dsRBDs
are capable of discriminating different hnRNAs in vivo.
Moreover, dsRBDs might not only contribute to sub-
strate specificity by targeting the protein to the proper
RNA. It has been suggested that dsRBD binding does help
to identify the base to be edited by facilitating its accessibil-
ity for deamination (Yi-Brunozzi et al., 2001). Therefore, it
is possible that binding of constructs carrying different com-
binations of dsRBDs could specifically allow access to
distinct adenosines within an RNA so regulating editing
specificity. In this case, specific exposure of a particular
adenosine might not only be mediated by the different
binding affinities exhibited by distinct dsRBDs, but also by
the structural differences observed for the interaction of cer-
tain dsRBDs with structured RNAs (Ryter and Schultz,
1998; Ramos et al., 2000).
Recently, human ADAR1 was reported to induce protein
translation within the nucleus (Herbert et al., 2002). This
activity is thought to occur on the surface of the nucleolus
and is independent of RNA editing. During the course of
our work, we noted that 
 
Xenopus
 
 ADAR1 also associates
with nucleoli and that some of our mutant constructs dis-
play differing affinities for nucleoli. However, given that
many RNA-binding proteins stick to nucleoli when overex-
pressed, we did not pay further attention to this fact. In light
of this potential novel function of ADAR,1 the phenome-
non of nucleolar association may deserve future attention.
 
Substrate recognition by dsRBD proteins
 
To date, at least 20 different dsRBD-containing proteins
have been identified from various species. Although some of
these proteins bind dsRNA rather promiscuously, others can
bind RNA very specifically, at least in vivo. Many of the pro-
teins that are capable of specific substrate recognition con-
tain multiple dsRBDs including the 
 
Drosophila
 
 Staufen
protein and the RNA-editing enzymes of the ADAR su-
perfamily. The role of individual dsRBDs in RNA recogni-
tion is not quite clear especially because it has been shown
that dsRBDs primarily interact with the backbone of
dsRNA, thus recognizing the specific structure of this RNA,
but not allowing any base interaction to occur. However, it
was also shown that different dsRBDs can bind dsRNAs
with different affinities in vitro and that multiple dsRBDs
can contribute to a cooperative binding effect (Bass et al.,
1994; Krovat and Jantsch, 1996). Therefore, it had been
suggested that only the combination of multiple dsRBDs
might allow an RNA-specific interaction to occur by super-
imposing the double-stranded regions in a substrate RNA
with the multiple dsRBDs in a protein (Fierro-Monti and
Mathews, 2000).
Our present paper indicates that whereas the presence of
multiple dsRBDs is important, dsRBD identity might con-
tribute more to overall substrate specificity than thus far ex-T
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pected. Our data indicate that constructs carrying different
dsRBDs localize to different nascent transcripts in vivo. In
this context, it is important to notice that in all of our con-
structs the spacing between dsRBDs was maintained. Thus,
it is rather unlikely that the different in situ localizations ob-
served are caused by a different three-dimensional distribu-
tion of dsRBDs.
Our results also demonstrated that whereas a single copy of
a particular dsRBD can target specific chromosomal sites, the
extent of chromosomal labeling increases when additional
copies of the same dsRBD are added. In principle, this in-
crease in chromosomal labeling could be explained by a loss
of binding specificity. However, if this was the case, one
would expect the labeling to become increasingly uniform,
which was not observed. Instead, it appeared that labeling in-
creased at selected sites with a few additional sites coming up
on the addition of more dsRBDs. Therefore, it seems that
constructs carrying multiple copies of the same dsRBD did
not loose binding specificity, but simply had an increased
binding affinity while maintaining selectivity. Novel sites that
were only detected by the multi-dsRBD constructs might re-
main below the limit of detection for the single dsRBD con-
structs. However, the addition of dsRBDs would increase the
affinity to these sites and, therefore, allow their detection.
It is also interesting to note that each of the dsRBDs con-
tributed differently to RNA association in vivo. Although
constructs containing single, double, or triple copies of
dsRBDs1 or 2 showed a speckled chromosomal distribution,
constructs containing a comparable number of dsRBD3
showed a rather homogeneous staining. This, in turn, sug-
gests that both dsRBDs1 and 2 might be able to recognize
specific structural features of an RNA, thus leading to a pref-
erential association with some RNAs, whereas dsRBD3
might bind all types of RNAs rather uniformly.
In vitro, dsRBD2 is the strongest RNA binder, whereas
dsRBD3 binds RNA moderately. dsRBD1 shows very little
RNA-binding capacity in vitro (Brooks et al., 1998). How-
ever, it is possible that dsRBD1 fails to associate with the ge-
neric double-stranded RNA substrate, rI/rC in vitro, but
binds other, more specific substrates with much higher affin-
ity. Similar differences in substrate binding had been ob-
served for other dsRBDs in the past and could thus explain
the observed discrepancies between in vitro and in vivo
RNA association.
Finally, it must also be considered that the different in situ
localizations caused by individual dsRBDs might not only
be mediated by the RNA-binding specificity of those do-
mains. Specific enrichment at some transcriptionally active
loops might also be caused via a protein-mediated associa-
tion of some dsRBDs with other components of the RNP
matrix. Such additional functions of dsRBDs have recently
been reported in several cases. Different domains in the
 
Drosophila
 
 Staufen protein, for instance, have been shown to
be required for RNA localization and translational repres-
sion (Micklem et al., 2000). Similarly, it was recently shown
that some dsRBDs might act as nuclear import and others
as nuclear export signals (Eckmann et al., 2001; Browna-
well and Macara, 2002). Additionally, dsRBDs might be
required for homo- and heterodimerization with other
dsRBDs (unpublished data).
Our work shows that, whether caused exclusively via
RNA binding or also through protein–protein interaction,
dsRBDs are the key determinants for association of the
ADAR1 protein with nascent transcripts. Furthermore, we
show for the first time that individual dsRBDs seemingly
mediate specific chromosomal association of the protein.
Thus, it appears that dsRBDs can contribute to initial sub-
strate discrimination at a genome wide level.
 
The special loop
 
Besides being found on the majority of nascent transcripts,
ADAR1 is also enriched at a particular chromosomal site re-
ferred to as the special loop. Although out of the scope of
this present work, a few general points can be made here.
Like for other loops, special loop enrichment depends solely
on the three endogenous dsRBDs; neither the ZBD nor the
deaminase domain plays a role in mediating enrichment at
this site. Interestingly, however, as soon as the endogenous
dsRBDs arrangement is disturbed, enrichment at this site is
lost; not even a triplication of an individual domain in the
context of the full-length protein is able to enrich at the spe-
cial loop. However, the special loop is transcriptionally silent
and seemingly represents an intranuclear storage site for
ADAR1 and other RNA-binding components. Therefore,
targeting of ADAR1 to this site most likely depends on the
protein’s ability to associate with other RNA components
rather than on its RNA binding ability.
 
Materials and methods
 
Epitope tagging of Adar1.1
 
A previously described myc-tagged version of ADAR1.1 containing six tan-
demly arranged myc tags upstream and downstream of the Adar1.1 cDNA
was used for these experiments (Eckmann and Jantsch, 1999). Addition-
ally, the 3
 
  
 
untranslated region of the 
 
Xenopus
 
 NO38 cDNA (Peculis and
Gall, 1992) containing a poly(A)
 
 
 
 tail had been cloned downstream of the
3
 
  
 
mycs to stabilize injected RNAs. For this study, this construct was modi-
fied by flanking the dsRBDs with unique restriction sites to allow removal
and insertion of different dsRBD combinations. A BclI site was introduced
immediately upstream of the first dsRBD and a KpnI site just after the end
of dsRBD3 by site-directed mutagenesis.
A GFP-tagged version of this construct was made by removing both sets
of myc tags and inserting a GFP gene in place of the 3
 
  
 
mycs. First, the 5
 
 
 
mycs were removed by digestion with XbaI and NdeI. During removal, the
original AUG annealed oligonucleotides containing a new in-frame AUG
were inserted between these sites. Second, the 3
 
 
 
 mycs were removed by
digestion with XhoI and NdeI. A GFP gene was introduced that had been
amplified via PCR from the pEGFP-N2 vector (CLONTECH Laboratories,
Inc.) using primers containing these restriction sites. The integrity of the fi-
nal construct was checked by sequencing.
 
Construction of Adar1.1 deletions
 
Deletion of the dsRBDs was accomplished by partially digesting the myc-
tagged construct with AvaI releasing a 970-bp fragment containing all
three dsRBDs. The vector was filled and re-ligated, maintaining the correct
reading frame. The 
 
 
 
-deaminase construct was made by digesting the
myc-tagged construct with EcoRV and XhoI, removing the 3
 
  
 
end of the
Adar1.1 ORF immediately downstream of dsRBD3 up to the start of the 3
 
 
 
mycs. The EcoRV and XhoI sites were filled and re-ligated, maintaining the
correct reading frame.
 
Minimal dsRBD constructs
 
Two minimal dsRBD constructs were used in this study. A construct con-
taining the end of the ZBD up to and including all of dsRBD3 was made,
partially digesting the full-length modified myc-tagged version ADAR1.1
with AvaI to release a 1528-bp fragment. The ends of this fragment were
filled, and the fragment was cloned in-frame into a modified version of
p-Bluescript that had been cut with BamHI, and the overhangs were filled.T
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Downstream of the BamHI site, six tandemly arranged myc tags followed
immediately by the 3
 
 
 
 untranslated region of the NO38 cDNA had been
introduced. Clones were verified for correct insert orientation by restriction
mapping and confirmed by sequencing.
The second minimal construct used removed the very end of the ZBD
from the construct described above (see previous paragraph). This was
achieved by digesting with XbaI (found in the polylinker) and BclI,
whereby removing the 5
 
 
 
 end of the construct up to the start of dsRBD1. A
PCR fragment was amplified using a forward primer containing an in-
frame XbaI site that annealed immediately after the end of the ZBD, and a
reverse primer that annealed across the BclI site at the start of the dsRBD1.
The fragment was digested with XbaI and BclI and ligated into the pre-
pared vector and verified by sequencing.
 
Single, double, and triplication dsRBD constructs
 
Individual dsRBDs were amplified from the full-length ADAR1.1 cDNA via
PCR using primers immediately upstream and downstream of the domain.
The 5
 
 
 
 primer contained an in-frame BamHI site and the 3
 
 
 
 primer con-
tained an in-frame KpnI site. After digestion with these enzymes, individ-
ual domains were ligated in the modified myc-tagged version of the
ADAR1.1 cDNA that had been cut with BclI and KpnI. All constructs were
verified by sequencing.
For duplication of individual domains, a common two-step PCR ap-
proach was used. Individual domains were first amplified using a 5
 
 
 
 primer
containing a BamHI site and a hybrid 3
 
 
 
 primer. The 3
 
 
 
 primer was de-
signed in a such a way that its 5
 
 
 
 half was complementary to the inverse
complementary sequence immediately upstream of the 5
 
 
 
 primer. Thus,
the PCR fragment of the first step could be used as a 5
 
 
 
 primer in the sec-
ond round of PCR in combination with a new 3  primer containing an in-
frame Kpn1 site. Primers were designed in such a way as to maintain the
same spacing between dsRBDs as is present in the wild-type situation. Af-
ter digestion with BamHI and KpnI, the duplicated domains were ligated
into both epitope-tagged versions of Adar1.1 that had been cut with BclI
and KpnI. Each construct was verified by sequencing.
Triplications of individual dsRBDs were made using restriction sites
unique in the individual domain and, hence, present twice in the duplica-
tion constructs. Each duplication construct was both fully and partially di-
gested with the relevant enzyme (dsRBD1   ClaI; dsRBD2   MscI; and
dsRBD3   Bsu65I). The insert released from complete digestion was ligated
into the partially digested vector creating a triplication construct. Insert ori-
entation was checked by restriction mapping and confirmed by sequencing.
Oocyte injections
Both myc- and GFP-tagged ADAR1 variants were linearized using a
unique SnaBI restriction site downstream of the NO38 poly(A)
  tail.
Capped run-off transcripts were synthesized in vitro from the linearized
template using T3 RNA polymerase (Stratagene). Aliquots of all RNAs were
checked for integrity on RNA gels by ethidium bromide staining. For single
injections of myc-tagged constructs, 50 oocytes were injected with 50 ng
RNA per oocyte and incubated for 24–72 h at 16 C in OR-2 (Wallace et
al., 1973) to allow translation to occur. For double injections of both myc-
and GFP-tagged variants, we first injected the GFP-tagged construct to
achieve optimal translation. 50 ng RNA per oocyte was injected and, after
a 12-h incubation (16 C in OR2), RNA transcribed from the myc-tagged
ADAR1 variants was injected (50 ng per oocyte). All oocytes were incu-
bated for a further 24–72 h at 16 C in OR2 to allow translation to occur.
LBC preparations and immunofluorescence stainings
LBC preparations and immunofluorescence stainings were performed as
described previously (Wu et al., 1991). Antibodies used were as follows:
anti–rabbit SAT3 (1:500) directed against Xenopus ADAR1.1 (Eckmann
and Jantsch, 1999); the anti–myc mAb 9E10 (1:1) directed against the myc
tag (Evan et al., 1985); and an anti–rabbit GFP antibody (1:1,000) directed
against the GFP tag (a gift from P. Silver, Dana-Farber Cancer Institute, Bos-
ton, MA). For GFP detection, a secondary anti–rabbit FITC antibody was
used. For all other stainings, appropriate combinations of secondary anti-
bodies were used as indicated. Microscopic images were captured on a
Zeiss fluorescence microscope equipped with an ORCA-cooled charged-
coupled device camera (Hamamatsu). Images were imported into Photo-
shop 5 (Adobe Systems) with the help of a plug-in module (QED-Imaging).
Western blots
Oocytes were manually dissected, and nuclei (germinal vesicles, GVs) and
cytoplasms were collected separately. Up to five cytoplasms were col-
lected in NET-2 buffer (Steitz, 1989), sonicated, and centrifuged to remove
insoluble material. The supernatant was mixed with an equal volume of
2  SDS sample buffer. Up to 20 GVs were directly collected into 2  SDS
sample buffer. Extracts corresponding to eight GVs and one cytoplasm
were loaded per lane on a 7% SDS-PAGE gel and blotted onto a polyvi-
nylidene difluoride membrane (Osmonic Inc.). Myc-tagged proteins were
detected with the mAb 9E10 and GFP-tagged proteins with a GFP mAb
(Boehringer). Both primary antibodies were detected with a secondary al-
kaline phosphatase–labeled anti–mouse antibody (Pierce Chemical Co.)
developed with the use of the chromogenic substrate NBT/BCIP.
Northwestern assays
For Northwestern assays of dsRBD constructs, the corresponding regions
were cloned into a suitable pGEX vector and expressed as GST fusion pro-
teins. Crude lysates from Escherichia coli expressing the proteins of interest
were separated on protein gels, blotted, and probed with radiolabeled rI/rC
as described previously (St Johnston et al., 1992). To determine the amount
of RNA bound, the autoradiograms were scanned using laser densitometry.
Furthermore, protein extracts were run on a second protein gel, stained
with Coomassie R250 (Sigma-Aldrich), and the amount of recombinant
protein was quantified by densitometry. The amount of RNA bound was
normalized to the amount of recombinant protein present in the extract.
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